valcopy
12-01-2022, 09:54 PM
007 Mitomycin C plus tegafur 1iDii 19 RCT PSK 3 g d Gastric cancer 262; 124; 129 Improved survival in the treatment group was clinically significant Mitomycin C plus oral fluorouracil 1iDiii 13 RCT PSK 3 g d Gastric cancer 21; 10; 11 Survival was improved significantly in treatment group UFT 300 mg d starting 2 wk after surgery and continuing for 1 y or until diagnosis of tumor recurrence 1iDii 26 Meta analysis summarizing 48 studies PSK various doses Colorectal cancer 3 trials; 1, 094 patients 5 y survival 79 priligy 60 mg ([Only registered and activated users can see links]) Tamoxifen resistant and sensitive breast cancer primary tumors express elements of pluripotency